Corrigendum to "SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo" [Cancer Lett. 351 (2014) 143-50
| Errataetall: |
ErratumFor: Cancer Lett. 2014 Aug 28;351(1):143-50. - PMID 24880078 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:486 |
|---|---|
| Enthalten in: |
Cancer letters - 486(2020) vom: 28. Aug., Seite 71-72 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Lu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 17.09.2020 published: Print-Electronic ErratumFor: Cancer Lett. 2014 Aug 28;351(1):143-50. - PMID 24880078 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.canlet.2020.05.010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310562252 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310562252 | ||
| 003 | DE-627 | ||
| 005 | 20231225140352.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.canlet.2020.05.010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1035.xml |
| 035 | |a (DE-627)NLM310562252 | ||
| 035 | |a (NLM)32475789 | ||
| 035 | |a (PII)S0304-3835(20)30264-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Lu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo" [Cancer Lett. 351 (2014) 143-50 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Cancer Lett. 2014 Aug 28;351(1):143-50. - PMID 24880078 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Ai, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Yanyan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Haotian |e verfasserin |4 aut | |
| 700 | 1 | |a Peng, Xia |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Min |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Ao |e verfasserin |4 aut | |
| 700 | 1 | |a Ding, Jian |e verfasserin |4 aut | |
| 700 | 1 | |a Geng, Meiyu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer letters |d 1976 |g 486(2020) vom: 28. Aug., Seite 71-72 |w (DE-627)NLM000147273 |x 1872-7980 |7 nnns |
| 773 | 1 | 8 | |g volume:486 |g year:2020 |g day:28 |g month:08 |g pages:71-72 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.canlet.2020.05.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 486 |j 2020 |b 28 |c 08 |h 71-72 | ||